Skip to Content

Join the 'Trulance' group to help and get support from people like you.

Trulance News

Synergy Pharmaceuticals Announces FDA Approval of Trulance (plecanatide) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Adults

Posted 14 Feb 2018 by Drugs.com

NEW YORK--(BUSINESS WIRE) January 25, 2018 – Synergy Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Trulance (plecanatide) 3 mg tablet for the once-daily treatment of irritable bowel syndrome with constipation (IBS-C) in adults. This is the second indication for Trulance, which is already approved for the treatment of adults with chronic ...

FDA Approves Trulance (plecanatide) for Chronic Idiopathic Constipation

Posted 25 Jan 2017 by Drugs.com

January 19, 2017 – The U.S. Food and Drug Administration today approved Trulance (plecanatide) for the treatment of Chronic Idiopathic Constipation (CIC) in adult patients. “No one medication works for all patients suffering from chronic gastrointestinal disorders,” said Julie Beitz, M.D., director of the Office of Drug Evaluation III in the FDA’s Center for Drug Evaluation and Research. “With th ...

Trulance Approved for Chronic Constipation

Posted 22 Jan 2017 by Drugs.com

FRIDAY, Jan. 20, 2017 – Trulance (plecanatide) has been approved by the U.S. Food and Drug Administration to treat persistent constipation of unknown (idiopathic) cause in adults. Some 42 million people in the United States are affected by constipation, according to the National Institutes of Health. Once-daily Trulance is designed to stimulate the upper gastrointestinal tract to secrete fluid ...

Ask a Question

Further Information

Related Condition Support Groups

Chronic Idiopathic Constipation, Irritable Bowel Syndrome

Trulance Patient Information at Drugs.com